Elaine Chen and Damian Garde

BioTech

Eli Lilly gets FDA approval to sell Mounjaro as obesity drug called Zepbound

Eli Lilly’s blockbuster drug tirzepatide, sold as Mounjaro for type 2 diabetes, has been cleared to treat obesity, making it the second in a highly

Elaine Chen and Damian Garde November 8, 2023

BioTech

Wegovy’s successful heart trial raises a vital question about weight loss

A landmark study that found the blockbuster obesity drug Wegovy reduces the chance of heart problems adds urgency to a basic question in medicine: what

Elaine Chen and Damian Garde August 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Elaine Chen and Damian Garde

Eli Lilly gets FDA approval to sell Mounjaro as obesity drug called Zepbound

Wegovy’s successful heart trial raises a vital question about weight loss

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe